心臟假體設備市場規模、佔有率和成長分析（按產品類型、材質類型、最終用途和地區分類）－2026-2033年產業預測

全球心臟瓣膜裝置市場規模預計在 2024 年達到 74.7 億美元，從 2025 年的 80.5 億美元成長到 2033 年的 146.9 億美元，在預測期（2026-2033 年）內複合年成長率為 7.8%。

全球心臟瓣膜假體市場的主要驅動力是人口老化。隨著人口老化，心血管系統發生結構和功能變化，導致主動脈瓣狹窄和心臟衰竭等疾病的風險增加。這種人口結構變化導致退化性心臟疾病的發生率不斷上升，需要透過手術或經皮治療來植入人工瓣膜和心律調節器。因此，由於住院和醫療手術的增加，對先進心臟瓣膜假體的需求激增。此外，技術創新也發揮關鍵作用，例如微創治療方法方案、生物相容性材料和3D列印瓣膜等技術的進步提高了安全性、有效性和長期治療效果。這些進步，加上透過智慧監測解決方案改善的術後護理以及更廣泛的治療選擇，確保了市場的持續成長。

推動全球心臟瓣膜器械市場發展的因素

全球心臟病發生率的不斷上升是推動全球心臟瓣膜假體市場擴張的關鍵因素。隨著瓣膜性心臟病和冠狀動脈疾病等疾病的日益普遍，對心臟瓣膜和血管移植物等人工瓣膜置換解決方案的需求也日益成長。這種需求的激增不僅推動了銷售，也促進了行業內的進步和創新，為心臟醫療技術的成長和發展創造了充滿活力的環境。因此，應對這些健康挑戰的持續努力將繼續推動市場向前發展，從而為患者帶來更好的治療選擇。

限制全球心臟假體市場的因素

全球心臟假體市場面臨著漫長而複雜的監管核准流程帶來的巨大挑戰。嚴格的監管要求，以及全面的臨床試驗和廣泛的測試，都可能阻礙新器械的及時上市。這種漫長的核准流程不僅扼殺了創新，也限制了患者獲得最新心臟技術的機會。因此，市場遭受的延誤阻礙了潛在救命解決方案的推出，最終影響了患者照護和心臟疾病治療的整體進展。

全球心臟假體市場趨勢

全球心臟瓣膜假體市場正日益傾向於微創手術，這反映了患者的偏好和臨床實踐的關鍵趨勢。經導管心臟瓣膜和導管修復系統等創新器械因其能夠縮短恢復時間並降低相關風險（與傳統手術方法相比）而備受青睞。切口較小的手術方式不僅提高了患者的舒適度，還改善了整體治療效果，從而推動了對這些技術的需求。在這些微創解決方案的推動下，隨著醫療機構優先考慮效率和患者滿意度，市場預計將持續成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管環境
• 案例研究
• 技術分析

全球心臟假體市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 心臟瓣膜
  • 機械心臟瓣膜
  • 生物瓣膜
  • 經導管心臟瓣膜置換術（TAVR）
• 心律調節器
  • 植入式心臟節律器
  • 體外心律調節器
• 其他
  • 心室輔助裝置（VAD）
  • 全人工心臟（TAH）

全球心臟假體市場規模（按材料類型和複合年成長率分類）（2026-2033 年）

• 生物基材料
  • 牛
  • 豬組織
• 合成材料
  • 鈦
  • 聚氨酯
  • 碳
• 混合材料

全球心臟假體市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 醫院
• 心臟中心和診所
• 門診手術中心
• 其他

全球心臟假體市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Abbott Laboratories（USA）
• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Edwards Lifesciences Corporation（USA）
• LivaNova PLC（UK）
• Biotronik（Germany）
• MicroPort Scientific Corporation（China）
• Meril Life Sciences Pvt. Ltd.（India）
• Lepu Medical Technology Co., Ltd.（China）
• CryoLife, Inc.（USA）
• AtriCure, Inc.（USA）
• Braile Biomedica（Brazil）
• Labcor Laboratorios Ltda.（Brazil）
• Lifetech Scientific Corporation（China）
• Shree Pacetronix Ltd.（India）
• TTK Healthcare Ltd.（India）
• Colibri Heart Valve LLC（USA）
• Berlin Heart GmbH（Germany）
• SynCardia Systems LLC（USA）
• Venus Medtech（Hangzhou）Inc.（China）

結論與建議

Global Cardiac Prosthetic Devices Market size was valued at USD 7.47 Billion in 2024 and is poised to grow from USD 8.05 Billion in 2025 to USD 14.69 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global market for cardiac prosthetic devices is primarily driven by the growing elderly population, which experiences structural and functional changes in the cardiovascular system, increasing susceptibility to conditions such as aortic stenosis and heart failure. This demographic shift leads to a heightened incidence of degenerative heart diseases, necessitating surgical or percutaneous interventions involving prosthetic valves or pacemakers. Consequently, there is a surging demand for advanced cardiac prosthetic devices, influenced by rising hospital admissions and medical procedures. Additionally, technological innovations play a crucial role, with developments such as minimally invasive options, biocompatible materials, and 3D-printed valves enhancing safety, effectiveness, and long-term outcomes. These advancements not only improve post-operative care through smart monitoring solutions but also expand treatment options, ensuring sustained market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Prosthetic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Prosthetic Devices Market Segments Analysis

Global Cardiac Prosthetic Devices Market is segmented by Product Type, Material Type, End-Use and region. Based on Product Type, the market is segmented into Heart Valves, Pacemakers and Others. Based on Material Type, the market is segmented into Biological Materials, Synthetic Materials and Hybrid Materials. Based on End-Use, the market is segmented into Hospitals, Cardiac Centers and Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Prosthetic Devices Market

The increasing prevalence of cardiac diseases worldwide serves as a significant catalyst for the expansion of the global cardiac prosthetic devices market. As conditions such as heart valve disease and coronary artery conditions become more common, there is a heightened demand for prosthetic solutions like heart valves and vascular grafts. This surge in need not only drives sales but also encourages advancements and innovation within the industry, creating a dynamic environment for growth and development in cardiac healthcare technologies. Consequently, the ongoing battle against these health challenges continues to propel the market forward, leading to enhanced treatment options for patients.

Restraints in the Global Cardiac Prosthetic Devices Market

The Global Cardiac Prosthetic Devices market faces significant challenges due to lengthy and complex regulatory approval processes. The stringent regulatory requirements, coupled with the need for comprehensive clinical trials and extensive testing, can impede the timely introduction of new devices. This protracted approval timeline not only stifles innovation but also limits patient access to the latest advancements in cardiac technology. As a result, the market may suffer from delays that prevent the adoption of potentially life-saving solutions, ultimately impacting patient care and overall progress in treating cardiac conditions.

Market Trends of the Global Cardiac Prosthetic Devices Market

The global cardiac prosthetic devices market is increasingly gravitating towards advancements in minimally invasive procedures, reflecting a significant trend in patient preference and clinical practice. These innovative devices, such as transcatheter heart valves and catheter-based repair systems, are gaining traction due to their ability to promote quicker recovery times and lower associated risks compared to traditional surgical approaches. The shift towards smaller incisions not only enhances patient comfort but also improves overall outcomes, driving demand for these technologies. As healthcare providers prioritize efficiency and patient satisfaction, the market is expected to see continued growth fueled by these minimally invasive solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Analysis

Global Cardiac Prosthetic Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Heart Valves
  • Mechanical Heart Valves
  • Tissue Heart Valves
  • Transcatheter Heart Valves (TAVR)
• Pacemakers
  • Implantable Pacemakers
  • External Pacemakers
• Others
  • Ventricular Assist Devices (VADs)
  • Total Artificial Hearts (TAH)

Global Cardiac Prosthetic Devices Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Biological Materials
  • Bovine Pericardium
  • Porcine Tissue
• Synthetic Materials
  • Titanium
  • Polyurethane
  • Carbon
• Hybrid Materials

Global Cardiac Prosthetic Devices Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Centers and Clinics
• Ambulatory Surgical Centers
• Others

Global Cardiac Prosthetic Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Material Type, End-Use)
  • US
  • Canada
• Europe (Product Type, Material Type, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material Type, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material Type, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material Type, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcor Laboratorios Ltda. (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifetech Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shree Pacetronix Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SynCardia Systems LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (Hangzhou) Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations